Wells Fargo Maintains Overweight on CVS Health, Lowers Price Target to $112

Benzinga · 3d ago
Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $123 to $112.